Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY® (ponesimod) tablets, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- ponesimod
- product_names
- Ponesimod
- ndc
- 43068-620, 43068-620-01, 43068-610, 43068-610-09, 43068-602, 43068-602-00, 43068-603, 43068-603-00, 43068-604, 43068-604-00, 43068-605, 43068-605-00, 43068-606, 43068-606-00, 43068-607, 43068-607-00, 43068-608, 43068-608-00, 43068-609, 43068-609-00, 43068-611, 43068-611-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en